The risk of deep venous thrombosis with oral contraceptives containing drospirenone
- PMID: 21511807
- DOI: 10.1136/bmj.d2519
The risk of deep venous thrombosis with oral contraceptives containing drospirenone
Comment on
-
Hormonal contraception and risk of venous thromboembolism: national follow-up study.BMJ. 2009 Aug 13;339:b2890. doi: 10.1136/bmj.b2890. BMJ. 2009. PMID: 19679613 Free PMC article.
-
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.BMJ. 2009 Aug 13;339:b2921. doi: 10.1136/bmj.b2921. BMJ. 2009. PMID: 19679614 Free PMC article.
-
Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.BMJ. 2011 Apr 21;342:d2139. doi: 10.1136/bmj.d2139. BMJ. 2011. PMID: 21511804 Free PMC article.
-
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.BMJ. 2011 Apr 21;342:d2151. doi: 10.1136/bmj.d2151. BMJ. 2011. PMID: 21511805 Free PMC article.
Similar articles
-
Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.Ann Pharmacother. 2010 May;44(5):898-903. doi: 10.1345/aph.1M649. Epub 2010 Apr 6. Ann Pharmacother. 2010. PMID: 20371756 Review.
-
The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.Contraception. 2007 May;75(5):344-54. doi: 10.1016/j.contraception.2006.12.019. Epub 2007 Feb 23. Contraception. 2007. PMID: 17434015 Clinical Trial.
-
Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.Contraception. 2014 Apr;89(4):253-63. doi: 10.1016/j.contraception.2014.01.023. Epub 2014 Feb 4. Contraception. 2014. PMID: 24576793 Clinical Trial.
-
Drospirenone and VTE.J Fam Plann Reprod Health Care. 2010 Jan;36(1):44. doi: 10.1783/147118910790291127. J Fam Plann Reprod Health Care. 2010. PMID: 20067674 No abstract available.
-
Drospirenone Litigation: Does the Punishment Fit the Crime?J Womens Health (Larchmt). 2017 Feb;26(2):99-102. doi: 10.1089/jwh.2016.6092. Epub 2016 Nov 17. J Womens Health (Larchmt). 2017. PMID: 27854556 Review.
Cited by
-
Hormonal therapies and venous thrombosis: Considerations for prevention and management.Res Pract Thromb Haemost. 2022 Aug 23;6(6):e12763. doi: 10.1002/rth2.12763. eCollection 2022 Aug. Res Pract Thromb Haemost. 2022. PMID: 36032216 Free PMC article.
-
Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.BMJ. 2015 May 26;350:h2135. doi: 10.1136/bmj.h2135. BMJ. 2015. PMID: 26013557 Free PMC article.
-
Control of endothelin-a receptor expression by progesterone is enhanced by synergy with Gata2.Mol Endocrinol. 2013 Jun;27(6):892-908. doi: 10.1210/me.2012-1334. Epub 2013 Apr 16. Mol Endocrinol. 2013. PMID: 23592430 Free PMC article.
-
Pulmonary embolism in a female collegiate cross-country runner presenting as nonspecific back pain.J Chiropr Med. 2012 Sep;11(3):215-20. doi: 10.1016/j.jcm.2011.08.008. J Chiropr Med. 2012. PMID: 23449383 Free PMC article.
-
Estrogen and thrombosis: controversies and common sense.Rev Endocr Metab Disord. 2011 Jun;12(2):77-84. doi: 10.1007/s11154-011-9178-0. Rev Endocr Metab Disord. 2011. PMID: 21559819 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources